UNICEF December 13, 2017 UNICEF announced today that funding for its Vaccine Independence Initiative (VII), a mechanism to help countries secure a sustainable supply of life-saving vaccines, has more than doubled in the past year, increasing from $15 million to Read More
Year: 2017
Press Release: Arsanis Announces Closing of Initial Public Offering
November 20, 2017 WALTHAM, Mass. and VIENNA–(BUSINESS WIRE Arsanis, Inc. (NASDAQ:ASNS), a clinical-stage biopharmaceutical company focused on applying monoclonal antibody immunotherapies to address serious infectious diseases, today announced the closing of its initial public offering of 4,600,000 shares of its Read More
Endpoints: Armed with a $47M round, Gates-backed Visterra aims at a PhIIb flu drug study
By John Carrol October 5, 2017 At the time Visterra made a bid early this year to go public, the timing was off. The boom of 2014 was long gone and the current bumper crop of IPOs had yet to Read More
Reuters: Africa to get state-of-art HIV drugs for $75 a year
By Kate Kelland and Ben Hirschl September 21, 2017 Makers of generic AIDS drugs will start churning out millions of pills for Africa containing a state-of-the-art medicine widely used in rich countries, after securing a multi-million dollar guarantee that caps Read More
Press Release: New high-quality antiretroviral therapy to be launched in South Africa, Kenya and over 90 low- and middle-income countries at reduced price
Clinton Health Access Initiative and UNAIDS September 21, 2017 A breakthrough pricing agreement has been announced which will accelerate the availability of the first affordable, generic, single-pill HIV treatment regimen containing dolutegravir (DTG) to public sector purchasers in low- and Read More
Press Release: Global Leaders Commit Support for UNFPA at London Family Planning Summit
July 13, 2017 LONDON – On World Population Day, 11 July, international donors at the landmark Family Planning Summit in London committed a total of $207 million to UNFPA, the United Nations Population Fund. The new funding will help support UNFPA’s Read More
Press Release: OraSure Technologies to Drive Accelerated Adoption of OraQuick® HIV Self-Test
Orasure Technologies, Inc. June 27, 2017 OraSure Technologies, Inc., a leader in point-of-care diagnostic tests and specimen collection devices, today announced a new agreement with the Bill & Melinda Gates Foundation that will enable OraSure to offer its OraQuick® HIV Read More
Press Release: Archaogen receives investment from the Bill & Melinda Gates Foundation to develop antibodies against gram-negative bacteria
Achaogen May 5, 2017 Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing novel antibacterials addressing multidrug-resistant (MDR) gram-negative infections, today announced that it has signed an agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to partner in Read More
Xconomy: Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis
By David Holley April 26, 2017 Arsanis, a Waltham, MA-based biotech co-founded by scientist and entrepreneur Tillman Gerngross to develop treatments for bacterial and viral infections, has raised a $45.5 million investment led by the Bill & Melinda Gates Foundation to finance a mid-stage Read More
AgFunder News: AgTech accelerator launches first startup bringing Gates Foundation for Boragen $10m series A
By Louisa Burwood-Taylor March 2, 2017 AgTech Accelerator, the venture development organization, has launched its first startup, Boragen, leading a $10 million Series A for the ag biotech startup. AgTech Accelerator invested $3 million of its current $20 million capital pool and facilitated Read More